Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma - Concepedia

Concepedia

Publication | Open Access

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

DOI Full Paper Access

220

Citations

34

References

2008

Year

Hung Huynh, Van Chanh Ngo, Joseph Fargnoli, Mark Ayers, Khee Chee Soo, Heng Nung Koong, Choon Hua Thng, Hock Soo Ong, Alexander Yaw Fui Chung, Pierce K. H. Chow,

Clinical Cancer Research

Abstract

This study provides a strong rationale for clinical investigation of brivanib in patients with HCC.

References

	Year	Citations

Page 1